Researchers at the Vanderbilt University are making significant progress in decoding the molecular genetics of ant communication that takes place through a waxy layer of odors that coats their bodies.
Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, recently earned a spot on Health Forum’s 19th annual Health Care’s Most Wired list, which recognizes U.S. hospitals and health systems with the best use of information technology.
Topgolf has launched a fundraiser for the University of Texas MD Anderson Cancer Center that allows Topgolf guests to help fund research into the interplay between physical activity, nutrition, obesity and cancer.
The University of North Carolina at Chapel Hill recently received $1.5 million in funding from the William R. Kenan Jr. Charitable Trust that will fund a three-year pilot program to serve rural clinics throughout the state.
Following a recent Justice Department case involving kickbacks that resulted in a $6 million settlement, the Corporate Whistleblower Center is calling on physicians to contact them about schemes involving blood testing labs that are paying doctors to order unnecessary tests.
Grady Health System’s Marcus Stroke and Neuroscience Center in Atlanta recently opened a new outpatient center that will focus on multidisciplinary care and is part of an expansion of the system’s research capabilities.
U.S. News & World Report recently ranked St. Jude Children’s Research Hospital in Memphis the top pediatric cancer hospital in the country, with St. Jude earning a perfect score and topping more than 5,000 medical centers throughout the country.
PatientPoint, a patient education and engagement solutions company, recently generated $140 million in investment from Searchlight Capital Partners and Silver Point Capital that will go towards expansion.
In an effort to make precision medicine more accessible, Rennova Health Inc. subsidiary Advanced Molecular Services Group (AMS Group) has partnered with Certainty Health to develop smartphone tools that will help incorporate patients’ genetic backgrounds into psychiatric treatment.
The U.S. Food and Drug Administration said it is taking steps to promote wider access to lower-cost alternatives to prescription medication and facilitating efforts to bring more generic medications to the market.dd Teaser here
The FDA recently designated CTL019 a breakthrough therapy, approving it for treatment of adult patients with relapsed and refractory (r/r) diffuse large B-cell lymphoma (DLBCL) whose treatments with two or more prior therapies have failed, Novartis said in a release.
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID) and Princeton University recently released research on the role of HFC-1 protein compounds on the herpes simplex virus (HSV) reactivation cycle.
Vermont cancer advocates, survivors and care givers recently visited the Statehouse to encourage legislation that could help reduce the rate of cancer within the state as part of the American Cancer Society Cancer Action Network’s (ACS CAN) Cancer Action Day.